Two Sigma Investments
FOMX

Two Sigma Investments’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Two Sigma Investments’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-91,656
Closed -$344K – 3843
2019
Q1 		$344K Buy
+91,656
New +$343K ﹤0.01% 2515

Other funds holding FOMX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Two Sigma Investments's FOMX Position: Q2 2019 in Review

Two Sigma Investments sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q2 2019, closing a stake of 91,656 shares — an estimated $344K sold.

Two Sigma Investments first reported a position in FOMX in Q1 2019 and held it in 1 quarter. The position peaked at $344K in Q1 2019. 58 funds tracked by Wall St. Rank hold FOMX as of Q2 2019.

  • Two Sigma Investments reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q2 2019 after selling out during the quarter.
  • Two Sigma Investments sold 91,656 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q2 2019, an estimated $344K.
  • Two Sigma Investments first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q1 2019 and held it in 1 quarter.
  • Two Sigma Investments's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $344K in Q1 2019.
  • 58 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q2 2019.

Based on Two Sigma Investments's 13F filing for Q2 2019, filed 14 Aug 2019.